| 1 |
34607938 | The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients. | 2021 Nov 15 |
1 |
| 2 |
31838663 | Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ. | 2020 Apr |
5 |
| 3 |
32067305 | Cytokine profile in children with food allergy following liver transplantation. | 2020 Mar |
1 |
| 4 |
32180132 | Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo. | 2020 Dec |
1 |
| 5 |
32719413 | Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients. | 2020 Jul 27 |
2 |
| 6 |
32736525 | FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake. | 2020 Jul 31 |
2 |
| 7 |
30124124 | Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy. | 2019 Jul |
2 |
| 8 |
30983820 | Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. | 2019 Apr 7 |
1 |
| 9 |
31087207 | Axonal Protection by Tacrolimus with Inhibition of NFATc1 in TNF-Induced Optic Nerve Degeneration. | 2019 Jul |
5 |
| 10 |
31949424 | Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice. | 2019 |
1 |
| 11 |
29314738 | Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors. | 2018 Mar |
1 |
| 12 |
29520229 | Tacrolimus Reverses UVB Irradiation-Induced Epidermal Langerhans Cell Reduction by Inhibiting TNF-α Secretion in Keratinocytes via Regulation of NF-κB/p65. | 2018 |
5 |
| 13 |
29527316 | Outcome of tacrolimus and vedolizumab after corticosteroid and anti-TNF failure in paediatric severe colitis. | 2018 |
2 |
| 14 |
27181115 | The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. | 2017 Jan |
1 |
| 15 |
28060893 | Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. | 2017 |
3 |
| 16 |
25315214 | Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. | 2016 Jun |
3 |
| 17 |
24707135 | Clinical management of inflammatory bowel disease in the organ recipient. | 2014 Apr 7 |
1 |
| 18 |
24951257 | A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. | 2014 Sep |
1 |
| 19 |
25531359 | Role of immunosuppressives in special situations: perianal disease and postoperative period. | 2014 |
1 |
| 20 |
22404745 | Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. | 2013 May |
1 |
| 21 |
23518805 | Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease. | 2013 May |
3 |
| 22 |
22132896 | Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. | 2012 Jan |
1 |
| 23 |
22576566 | [Treatment strategy for refractory inflammatory bowel disease to improve endoscopic lesions and long-term prognosis]. | 2012 |
1 |
| 24 |
22579702 | Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation. | 2012 Aug |
2 |
| 25 |
22885734 | Tacrolimus down-regulates chemokine expressions on rheumatoid synovial fibroblasts: screening by a DNA microarray. | 2012 Dec |
1 |
| 26 |
22895606 | Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts. | 2012 Nov |
4 |
| 27 |
20238216 | FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes. | 2011 Jul |
2 |
| 28 |
21172435 | Surfactant protein A (SP-A)-tacrolimus complexes have a greater anti-inflammatory effect than either SP-A or tacrolimus alone on human macrophage-like U937 cells. | 2011 Apr |
1 |
| 29 |
21434949 | Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy. | 2011 Apr |
1 |
| 30 |
19880819 | Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. | 2010 Oct |
1 |
| 31 |
20159692 | [Effect of FK506 on cytokine secretion in whole blood]. | 2010 Feb |
2 |
| 32 |
18957484 | Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway. | 2009 Oct |
1 |
| 33 |
19153737 | Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies. | 2009 Sep |
1 |
| 34 |
18262659 | Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. | 2008 Mar |
1 |
| 35 |
17568575 | Polymorphisms of tumor necrosis factor-alpha, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus. | 2007 Aug |
1 |
| 36 |
17880416 | Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. | 2007 Oct |
2 |
| 37 |
16303143 | Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. | 2006 Apr 18 |
3 |
| 38 |
16930148 | Tacrolimus treatment of plasmacytoid dendritic cells inhibits dinucleotide (CpG-)-induced tumour necrosis factor-alpha secretion. | 2006 Dec |
1 |
| 39 |
16985094 | Novel therapies for Crohn's disease: focus on immunomodulators and antibiotics. | 2006 Oct |
1 |
| 40 |
17149058 | Behçet disease: recommendation for clinical management of mucocutaneous lesions. | 2006 Dec |
1 |
| 41 |
15598440 | FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. | 2005 Jan 21 |
2 |
| 42 |
15851377 | FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients. | 2005 Mar 29 |
3 |
| 43 |
16181452 | FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. | 2005 Oct |
3 |
| 44 |
15243524 | Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. | 2004 Jul |
1 |
| 45 |
15377358 | FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. | 2004 Sep |
1 |
| 46 |
12621554 | [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts]. | 2003 Mar |
1 |
| 47 |
11169223 | Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production. | 2001 Feb |
1 |
| 48 |
11428741 | Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues. | 2001 Jun |
2 |
| 49 |
11523700 | Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. | 2001 Sep |
1 |
| 50 |
10928971 | FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. | 2000 Aug |
4 |